NN9541 / Novo Nordisk  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NN9541 / Novo Nordisk
NCT06326047: A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes

Recruiting
2
288
Canada, Japan, US, RoW
NNC0519-0130, Placebo, Trizepatide
Novo Nordisk A/S
Diabetes Mellitus, Type 2
11/24
08/25
NCT06326060: A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight

Recruiting
2
343
Japan, US, RoW
NNC0519-0130, Placebo, Tirzepatide
Novo Nordisk A/S
Obesity
11/24
05/25

Download Options